Project Overview
Maculus Therapeutix is a pioneering biotech company dedicated to transforming the treatment landscape for macular degeneration—one of the world’s leading causes of vision impairment and blindness. Through cutting-edge research and targeted therapeutics, the company is working to address the root causes of retinal degeneration, with the goal of preserving and improving the lives of millions. With a deep commitment to scientific progress and patient-centric outcomes, Maculus Therapeutix is positioning itself at the forefront of ophthalmic innovation. Sleem Hasan was brought in as a strategic advisor to support the company’s clinical positioning, growth readiness, and investor communications.
Key Objectives
Refine Scientific Narrative for Investors
Translate advanced R&D into a clear and compelling investment story for non-technical stakeholders.Position Maculus as a Vision Health Innovator
Define category leadership through differentiation in both treatment approach and clinical relevance.Support Clinical & Market Strategy
Align research milestones with go-to-market frameworks and long-term commercial planning.Prepare for Early-Stage Fundraising
Structure investor-facing materials and support capital raise strategy for trials and development phases.
Our Approach
1
Scientific Storytelling
Narrative Development: Simplified complex medical advancements into compelling language for investors and strategic partners.
Category Framing: Positioned macular degeneration not just as a clinical challenge, but as a scalable impact opportunity in aging societies.
2
Clinical Growth Strategy
Milestone Roadmapping: Aligned R&D phases with targeted investment milestones and risk-managed go-to-market plans.
Pipeline Clarity: Helped refine and present therapeutic pipeline in terms of both clinical potential and patient benefit.
3
Investor Engagement
Deck & Presentation Refinement: Transformed technical materials into digestible, capital-raising assets.
Advisory Representation: Provided mentorship on engaging with biotech investors, institutional partners, and healthcare-focused VCs.
4
Long-Term Value Framing
Impact Highlighting: Helped frame the company’s mission around societal value—improving independence, longevity, and quality of life for an aging global population.
Strategic Counsel: Ongoing support on vision alignment, competitive positioning, and multi-phase development planning.